TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; TELMISARTAN) — FDA Approval ANDA202544 (GLENMARK PHARMS LTD)
TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; TELMISARTAN) — FDA Approval ANDA202544 (GLENMARK PHARMS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TELMISARTAN AND HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; TELMISARTAN; Application number: AND
| Brand name | TELMISARTAN AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE; TELMISARTAN |
| Application number | ANDA202544 |
| Sponsor | GLENMARK PHARMS LTD |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20190304 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →